Fluvastatin Capsule
Product Images NDC 72162-1034

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 72162-1034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fluvastatin (Image 1)

Chemical structure diagram of fluvastatin, showing its molecular composition including fluorophenyl, indole, hydroxyl, and carboxylate groups with a sodium ion.*

FDA Label Image

1 (Image 2)

A Kaplan-Meier survival curve chart depicting the percentage of patients without event over approximately 4.5 years since randomization. It compares Fluvastatin 80 mg versus placebo groups, with survival percentages plotted on the y-axis and years since randomization on the x-axis. The chart includes a table showing patients at risk and survival percentages at multiple time points and a statistics box with p-values and a hazard ratio with 95% confidence interval.*

FDA Label Image

1 (Image 3)

A forest plot chart showing incidence, risk reduction percentage, and Cox risk ratio with 95% confidence intervals for various cardiac events comparing Fluvastatin and placebo. It includes primary and secondary endpoints such as cardiac death, nonfatal MI, revascularization, and noncardiac death, illustrating the relative risk favoring Fluvastatin or placebo.*

FDA Label Image

1 (Image 4)

A bar chart depicting change in minimum lumen diameter (mm) comparing Fluvastatin and placebo treatments across three groups: Monotherapy, All Patients, and Combination Therapy (with cholestyramine, CME). Bars show numerical values and p-values for each comparison, illustrating treatment effects on lumen diameter.*

FDA Label Image

1 (Image 5)

A bar chart comparing the percent change in diameter stenosis across three patient groups: Monotherapy, All Patients, and Combination Therapy, each with Fluvastatin and Placebo arms. Percent changes and p-values for statistical significance between groups are shown. Combination Therapy includes cholestyramine (CME).*

FDA Label Image

Label (Lbl721621034)

Fluvastatin Capsules, USP 40 mg oral capsules, relabeled by Bryant Ranch Prepack and manufactured by Teva Pharmaceutical Ind. Ltd. The label includes NDC 72162-1034-1, a quantity of 100 capsules, storage instructions at 20° to 25°C, and a note to keep medications out of children's reach. It also features a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.